论文部分内容阅读
选取肝炎后肝硬化并上消化道出血患者200例作为研究对象,随机分为对照组和研究组各100例。两组患者均给予奥美拉唑治疗,研究组在此基础上联合奥曲肽治疗;对照组在此基础上联合垂体后叶素治疗,对两组患者的疗效进行比较。结果研究组患者治疗有效率为97%,对照患者治疗有效率为95%,差异无统计学意义(P>0.05)。且研究组不良反应发生率为5%,显著低于对照组的17%(P<0.05)。使用奥曲肽治疗治疗肝炎后肝硬化并上消化道出血不良反应发生率较低且轻,比较安全,值得推广使用。
Two hundred and seventy patients with posthepatitic cirrhosis and upper gastrointestinal hemorrhage were selected as study subjects and randomly divided into control group and study group with 100 cases each. Both groups were given omeprazole treatment, the study group on this basis combined with octreotide treatment; the control group on the basis of pituitrin treatment, the efficacy of the two groups of patients were compared. Results The effective rate of treatment was 97% in the study group and 95% in the control group, with no significant difference (P> 0.05). The incidence of adverse reactions in the study group was 5%, which was significantly lower than 17% in the control group (P <0.05). The use of octreotide treatment of posthepatitic cirrhosis and upper gastrointestinal bleeding adverse reaction rate is lower and lighter, safer, it is worth promoting the use of.